Marketing, Author at VIPOC

Vitiligo research

VITILIGO: A REVIEW OF SOME FACTS LESSER KNOWN ABOUT DEPIGMENTATION

James J Nordlund Abstract Vitiligo is a disorder that causes the destruction of melanocytes. It…

Marketing10 November 2022

News

VIPOC Appoints Mrs. Gaone Matewa As New President

NEWS RELEASE …

Marketing1 November 2022

Vitiligo research

FDA Approves New Vitiligo Treatment, Ruxolitinib (Opzelura) The JAK inhibitor cream is the first medication that can restore pigment in people with this autoimmune disease.

By Becky Upham July 22, 2022 On July 18, the U.S. Food and Drug Administration…

Marketing27 July 2022

News

3RD VIPOC CONFERENCE 21ST-23RD APRIL 2022 AMSTERDAM (THE NETHERLANDS)

50 attendees - 20 nations 20 leaders of vitiligo organizations from all over the world,…

Marketing9 June 2022

© 2022 VIPOC. Copyright © VIPOC Built by Simboti Digital All rights reserved.|Privacy Policy - English|Privacy Policy - French